SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-15-008187
Filing Date
2015-09-28
Accepted
2015-09-28 17:29:20
Documents
5
Effectiveness Date
2015-09-28

Document Format Files

Seq Description Document Type Size
1 S-8 ctic-s8_20150923.htm S-8 138331
2 EX-4.1 ctic-ex41_207.htm EX-4.1 155165
3 EX-5.1 ctic-ex51_208.htm EX-5.1 12557
4 EX-15 ctic-ex15_209.htm EX-15 3597
5 EX-23.1 ctic-ex231_210.htm EX-23.1 2918
  Complete submission text file 0001564590-15-008187.txt   313668
Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-207176 | Film No.: 151128365
SIC: 2834 Pharmaceutical Preparations